$8.39 -0.07 (-0.83%)
11/27/2009 1:00 PM

Incyte Corp (INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Featured Broker Partners